Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.
Institute of Biochemistry, Biological Research Centre, Szeged, Hungary.
Nat Commun. 2023 Sep 16;14(1):5746. doi: 10.1038/s41467-023-41393-5.
Streptococcus pyogenes Cas9 (SpCas9) has been employed as a genome engineering tool with a promising potential within therapeutics. However, its off-target effects present major safety concerns for applications requiring high specificity. Approaches developed to date to mitigate this effect, including any of the increased-fidelity (i.e., high-fidelity) SpCas9 variants, only provide efficient editing on a relatively small fraction of targets without detectable off-targets. Upon addressing this problem, we reveal a rather unexpected cleavability ranking of target sequences, and a cleavage rule that governs the on-target and off-target cleavage of increased-fidelity SpCas9 variants but not that of SpCas9-NG or xCas9. According to this rule, for each target, an optimal variant with matching fidelity must be identified for efficient cleavage without detectable off-target effects. Based on this insight, we develop here an extended set of variants, the CRISPRecise set, with increased fidelity spanning across a wide range, with differences in fidelity small enough to comprise an optimal variant for each target, regardless of its cleavability ranking. We demonstrate efficient editing with maximum specificity even on those targets that have not been possible in previous studies.
化脓链球菌 Cas9(SpCas9)已被用作基因组工程工具,在治疗方面具有广阔的应用前景。然而,其脱靶效应是高度特异性应用的主要安全隐患。迄今为止,为了减轻这种效应而开发的方法,包括任何提高保真度(即高保真度)的 SpCas9 变体,仅在相对较小的一部分目标上提供有效的编辑,而没有可检测到的脱靶效应。在解决这个问题的过程中,我们揭示了一个相当出乎意料的靶序列可切割性排名,以及一个控制提高保真度 SpCas9 变体的靶和脱靶切割的规则,但不能控制 SpCas9-NG 或 xCas9。根据这一规则,对于每个靶标,必须确定具有匹配保真度的最佳变体,以实现高效切割而无可检测的脱靶效应。基于这一见解,我们在这里开发了一套扩展的变体,即 CRISPRecise 变体集,具有广泛的提高保真度范围,其保真度差异足够小,可为每个靶标包含一个最佳变体,而不管其可切割性排名如何。我们展示了即使在以前的研究中不可能的那些靶标上也能实现高效的特异性编辑。